Skip to content

Correlation Between Quantitative Analysis of Coronary MRA and FFR

Quantitative Analysis of 3T Whole Heart Coronary Magnetic Resonance Angiogram Improves Detection of Functionally Significant Coronary Artery Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03117218
Enrollment
89
Registered
2017-04-17
Start date
2014-07-01
Completion date
2018-05-31
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Fractional Flow Reserve, Magnetic Resonance Angiography

Brief summary

This study aims to evaluate whether quantitative analysis of coronary MR angiogram would improve the detection of functionally-significant coronary artery stenosis.

Detailed description

Coronary MR angiography is performed with a 3.0-T imager with 32-channel coils. Qunatitative analysis of coronary MR angiogram is evaluated on the basis of the signal intensity (SI) profile along the vessel. Quantitative analysis of coronary MR angiogram (QCMRA) is calculated as \[1 - (SImin/SIref)\] x 100, where SImin is minimal SI and SIref is corresponding reference SI. Diagnostic performance of quantitative analysis of coronary MR angiogram for predicting functional significant coronary stenosis was evaluated by using fractional flow reserve (FFR) as the reference standard.

Interventions

DIAGNOSTIC_TESTCoronary MR angiography

Quantitative analysis of coronary MR angiogram

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * 1 or more coronary stenoses in the major coronary artery with a vessel diameter ≥ 2mm on coronary MR angiogram * Patient who were planned to undergo invasive coronary angiography and fractional flow reserve

Exclusion criteria

* clinically unstable patient * a history of coronary revascularization * infiltrative cardiomyopathy, hypertropic cardiomyopathy, myocarditis * contraindication to use of adenosine * complete occlusion of target lesion

Design outcomes

Primary

MeasureTime frameDescription
Presence of functionally significant coronary stenosiswithin 1 monthfractional flow reserve \< 0.8

Countries

South Korea

Contacts

Primary ContactYeonyee E Yoon, MD
yeonyeeyoon@snubh.org+82-31-787-7072

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026